ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978

SAIC-Frederick Makes Awards To Proteomics Research Teams.

January 14, 2005

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010